There were 224 press releases posted in the last 24 hours and 454,454 in the last 365 days.

Bladder Cancer Drugs Market Players Invest In Nanotechnology

Bladder Cancer Drugs Global Market Report

Bladder Cancer Drugs Global Market Report 2022– Market Size, Trends, And Global Forecast 2022-2026

The Business Research Company’s Bladder Cancer Drugs Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

LONDON, GREATER LONDON, UK, March 14, 2022 / -- Global bladder cancer drugs market leaders are investing on the research to utilize nano-technology as a means to deliver drugs into the human body. Nanotechnology is the design, characterization, production, and application of devices, structures and systems by controlled manipulation of size and shape at the nanometer scale. Bladder cancer drugs market trends include this method of delivery which helps doctors to offer a simple and effective way of treating bladder cancer in their patients, due to the fact that the nanoparticles used in the treatment can attack the cancerous cells directly without harming the surrounding cells. For instance, the Center for Drug Research And Development in Canada has pledged a $1.2 million investment in Sitka biopharma to help with development activities for clinical trials of STK-01, a product to treat bladder cancer using nanotechnology.

The number of bladder cancer cases has been on the rise. Factors such as unhygienic workplace exposures, increase in smoking habits and consuming water that contains Arsenic increases the chances of blood cancer. According to American Cancer Society, there were 81,400 new cases of bladder cancer in 2020 out of which a total of 62,100 cases were in men and 19,300 cases in women. This increased incidence of bladder cancer increases the demand for bladder cancer drugs, contributing to the growth of the market.

Read more on the Global Bladder Cancer Drugs Market Report:

The global bladder cancer drugs market size is expected to grow from $1.98 billion in 2021 to $2.35 billion in 2022 at a compound annual growth rate (CAGR) of 19.1%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global bladder cancer drug market size is expected to reach $4.45 billion in 2026 at a CAGR of 17.3%.

Major players covered in the global bladder cancer drugs industry are Pfizer, Celgene Corporation, Eli Lilly, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Sanofi, Hoffmann-La Roche, Novartis International and Johnson & Johnson.

North America is the largest region in the bladder cancer drugs market in 2021. The Middle East is expected to be the fastest growing region in the bladder cancer drug market during the forecast period. The regions covered in the bladder cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

TBRC’s global bladder cancer drugs market growth analysis report is segmented by type into non-muscle-invasive bladder cancer, muscle-invasive bladder cancer, by application into low-grade tumors, high-grade tumors, by distribution channel into hospital pharmacy, retail pharmacy, others.

Bladder Cancer Drugs Global Market Report 2022 – By Type (Non-Muscle-Invasive Bladder Cancer, Muscle-Invasive Bladder Cancer), By Application (Low-Grade Tumors, High-Grade Tumors), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) – Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides a bladder cancer drugs market overview, forecast bladder cancer drugs market size and bladder cancer drugs market growth for the whole market, bladder cancer drugs market segments, bladder cancer drugs market geographies, bladder cancer drugs market trends, bladder cancer drugs market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request for a Sample of the Global Bladder Cancer Drugs Market Report:

Not what you were looking for? Here is a list of similar reports by The Business Research Company:

Pancreatic Cancer Drugs Global Market Report 2022 – By Type (Endocrine Pancreatic Cancer, Exocrine Pancreatic Cancer), By End User (Hospitals, Clinics, Others), By Drugs (Afinitor, Erlotinib, Hydrochloride Everolimus, 5-FU, Flurouracil, Gemcitanine, Abraxane) – Market Size, Trends, And Global Forecast 2022-2026

Cancer Diagnostics Global Market Report 2021 - By Products (Companion Diagnostics, Molecular Diagnostics), By End-User (Cancer Research Institutes, Diagnostic Laboratories, Hospitals), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma), COVID-19 Growth And Change

Prostate Cancer Drugs Global Market Report 2022 – By Type (Hormone Sensitive Prostate Cancer, Hormone Refractory Prostate Cancer), By Therapy (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy), By End User (Hospitals, Clinics) – Market Size, Trends, And Global Forecast 2022-2026

Know More About The Business Research Company?
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Read more about us at

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Check out our:

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
Visit us on social media:

Market Research Products, Services, Solutions For Your Business - TBRC